Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study

Emanuele Crocetti, Laurent Roche, Carlotta Buzzoni, Francesco Di Costanzo, Florence Molinié, Adele Caldarella, GRELL EUROCARE-5 Working Group

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE. BC data from six countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) were extracted from the EUROCARE-5 database. First, we focus on 1- and 5-year age-standardized net survival (NS) from BC by country over the 2000-2004 period. Then, trends in NS over the 1989-2004 period and changes in the pattern of cancer excess mortality rate (EMR) up to 5 years after diagnosis were examined using a multivariate EMR model. There were little differences in age-standardized NS from BC. Over the 2000-2004 period, the 5-year survival ranged between 82 (Spain, Belgium, and Portugal) and 86% (France). There was an increase in agestandardized survival between 1989 and 2004 at 1 year as well as at 5 years. This increase was observed at all ages and in all countries. There was a decrease in the cancer EMR both immediately after diagnosis and by the second and third year of follow-up. There were only minor differences in survival from BC between European Latin countries. The general improvement in NS is presumably because of advances in early cancer diagnosis and improvements in treatment.

Original languageEnglish
Pages (from-to)S85-S91
JournalEuropean Journal of Cancer Prevention
Volume26
Issue numberTrends in cancer net survival in six European Latin Countries
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Breast Neoplasms
Mortality
Population
Portugal
Belgium
Spain
France
Neoplasms
Delivery of Health Care
Switzerland
Early Detection of Cancer
Italy
Epidemiology
Language
Databases

Keywords

  • Breast cancer
  • Cancer registries
  • Europe
  • Excess mortality rate
  • Latin countries
  • Net survival
  • Trend analysis

ASJC Scopus subject areas

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Crocetti, E., Roche, L., Buzzoni, C., Di Costanzo, F., Molinié, F., Caldarella, A., & GRELL EUROCARE-5 Working Group (2017). Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study. European Journal of Cancer Prevention, 26(Trends in cancer net survival in six European Latin Countries), S85-S91. https://doi.org/10.1097/CEJ.0000000000000291

Trends in net survival from breast cancer in six European Latin countries : Results from the SUDCAN population-based study. / Crocetti, Emanuele; Roche, Laurent; Buzzoni, Carlotta; Di Costanzo, Francesco; Molinié, Florence; Caldarella, Adele; GRELL EUROCARE-5 Working Group.

In: European Journal of Cancer Prevention, Vol. 26, No. Trends in cancer net survival in six European Latin Countries, 01.01.2017, p. S85-S91.

Research output: Contribution to journalArticle

Crocetti, E, Roche, L, Buzzoni, C, Di Costanzo, F, Molinié, F, Caldarella, A & GRELL EUROCARE-5 Working Group 2017, 'Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study', European Journal of Cancer Prevention, vol. 26, no. Trends in cancer net survival in six European Latin Countries, pp. S85-S91. https://doi.org/10.1097/CEJ.0000000000000291
Crocetti E, Roche L, Buzzoni C, Di Costanzo F, Molinié F, Caldarella A et al. Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study. European Journal of Cancer Prevention. 2017 Jan 1;26(Trends in cancer net survival in six European Latin Countries):S85-S91. https://doi.org/10.1097/CEJ.0000000000000291
Crocetti, Emanuele ; Roche, Laurent ; Buzzoni, Carlotta ; Di Costanzo, Francesco ; Molinié, Florence ; Caldarella, Adele ; GRELL EUROCARE-5 Working Group. / Trends in net survival from breast cancer in six European Latin countries : Results from the SUDCAN population-based study. In: European Journal of Cancer Prevention. 2017 ; Vol. 26, No. Trends in cancer net survival in six European Latin Countries. pp. S85-S91.
@article{17238ab2eab64bd9bb914e280f33cbe7,
title = "Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study",
abstract = "Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE. BC data from six countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) were extracted from the EUROCARE-5 database. First, we focus on 1- and 5-year age-standardized net survival (NS) from BC by country over the 2000-2004 period. Then, trends in NS over the 1989-2004 period and changes in the pattern of cancer excess mortality rate (EMR) up to 5 years after diagnosis were examined using a multivariate EMR model. There were little differences in age-standardized NS from BC. Over the 2000-2004 period, the 5-year survival ranged between 82 (Spain, Belgium, and Portugal) and 86{\%} (France). There was an increase in agestandardized survival between 1989 and 2004 at 1 year as well as at 5 years. This increase was observed at all ages and in all countries. There was a decrease in the cancer EMR both immediately after diagnosis and by the second and third year of follow-up. There were only minor differences in survival from BC between European Latin countries. The general improvement in NS is presumably because of advances in early cancer diagnosis and improvements in treatment.",
keywords = "Breast cancer, Cancer registries, Europe, Excess mortality rate, Latin countries, Net survival, Trend analysis",
author = "Emanuele Crocetti and Laurent Roche and Carlotta Buzzoni and {Di Costanzo}, Francesco and Florence Molini{\'e} and Adele Caldarella and {GRELL EUROCARE-5 Working Group}",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/CEJ.0000000000000291",
language = "English",
volume = "26",
pages = "S85--S91",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "Trends in cancer net survival in six European Latin Countries",

}

TY - JOUR

T1 - Trends in net survival from breast cancer in six European Latin countries

T2 - Results from the SUDCAN population-based study

AU - Crocetti, Emanuele

AU - Roche, Laurent

AU - Buzzoni, Carlotta

AU - Di Costanzo, Francesco

AU - Molinié, Florence

AU - Caldarella, Adele

AU - GRELL EUROCARE-5 Working Group

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE. BC data from six countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) were extracted from the EUROCARE-5 database. First, we focus on 1- and 5-year age-standardized net survival (NS) from BC by country over the 2000-2004 period. Then, trends in NS over the 1989-2004 period and changes in the pattern of cancer excess mortality rate (EMR) up to 5 years after diagnosis were examined using a multivariate EMR model. There were little differences in age-standardized NS from BC. Over the 2000-2004 period, the 5-year survival ranged between 82 (Spain, Belgium, and Portugal) and 86% (France). There was an increase in agestandardized survival between 1989 and 2004 at 1 year as well as at 5 years. This increase was observed at all ages and in all countries. There was a decrease in the cancer EMR both immediately after diagnosis and by the second and third year of follow-up. There were only minor differences in survival from BC between European Latin countries. The general improvement in NS is presumably because of advances in early cancer diagnosis and improvements in treatment.

AB - Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE. BC data from six countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) were extracted from the EUROCARE-5 database. First, we focus on 1- and 5-year age-standardized net survival (NS) from BC by country over the 2000-2004 period. Then, trends in NS over the 1989-2004 period and changes in the pattern of cancer excess mortality rate (EMR) up to 5 years after diagnosis were examined using a multivariate EMR model. There were little differences in age-standardized NS from BC. Over the 2000-2004 period, the 5-year survival ranged between 82 (Spain, Belgium, and Portugal) and 86% (France). There was an increase in agestandardized survival between 1989 and 2004 at 1 year as well as at 5 years. This increase was observed at all ages and in all countries. There was a decrease in the cancer EMR both immediately after diagnosis and by the second and third year of follow-up. There were only minor differences in survival from BC between European Latin countries. The general improvement in NS is presumably because of advances in early cancer diagnosis and improvements in treatment.

KW - Breast cancer

KW - Cancer registries

KW - Europe

KW - Excess mortality rate

KW - Latin countries

KW - Net survival

KW - Trend analysis

UR - http://www.scopus.com/inward/record.url?scp=85010198868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010198868&partnerID=8YFLogxK

U2 - 10.1097/CEJ.0000000000000291

DO - 10.1097/CEJ.0000000000000291

M3 - Article

AN - SCOPUS:85010198868

VL - 26

SP - S85-S91

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - Trends in cancer net survival in six European Latin Countries

ER -